tiprankstipranks
Trending News
More News >
Sumitomo Chemical Co Ltd (JP:4005)
:4005
Japanese Market
Advertisement

Sumitomo Chemical Co (4005) Earnings Dates, Call Summary & Reports

Compare
1 Followers

Earnings Data

Report Date
Jan 30, 2026
TBA (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-1.74
Last Year’s EPS
21.46
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were significant improvements in core operating income and Sumitomo Pharma's performance, the overall sales revenue declined, and nonrecurring losses impacted the financials. The sentiment is balanced by positive strides in financial position and certain segments.
Company Guidance
During the fiscal year 2025 second quarter conference call, Sumitomo Chemical's core operating income increased significantly by JPY 79.2 billion year-over-year, reaching JPY 108.7 billion, while net income attributable to owners of the parent rose by JPY 46.2 billion to JPY 39.7 billion. Sales revenue, however, decreased by JPY 146 billion to JPY 1,954 billion. The company benefited from strong sales at Sumitomo Pharma, foreign exchange gains due to a weaker yen, and a reduction in corporate income tax expenses. Despite a loss of JPY 5 billion in nonrecurring items this quarter, the company recorded an operating income of JPY 103.7 billion. The average exchange rate was JPY 146.02 to $1, and the naphtha price was JPY 64,900 per kiloliter. For the full fiscal year, Sumitomo Chemical revised its core operating profit forecast to JPY 185 billion, anticipating a JPY 35 billion increase compared to the previous forecast, attributed to improved performance trends and partial sales of Petro Rabigh shares.
Significant Improvement in Core Operating Income
Core operating income increased by JPY 79.2 billion year-over-year to JPY 108.7 billion, driven by strong sales at Sumitomo Pharma and favorable foreign exchange and tax adjustments.
Sumitomo Pharma Performance
Sumitomo Pharma's core operating income increased by JPY 94.3 billion year-over-year, attributed to expanded sales of ORGOVYX and GEMTESA, as well as gains from partial divestiture of the Asian business.
Essential & Green Materials Segment Improvement
Despite a loss, the Essential & Green Materials segment saw an improvement of JPY 16.1 billion year-over-year due to better profit margins from synthetic resins and aluminum.
Financial Position Strengthening
Interest-bearing liabilities decreased by JPY 94.5 billion, and equity increased by JPY 105.2 billion compared to the previous term's end.

Sumitomo Chemical Co (JP:4005) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

JP:4005 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 30, 2026
2025 (Q3)
-1.74 / -
21.46
Nov 04, 2025
2025 (Q2)
23.33 / 27.02
-18.9242.96% (+45.92)
Aug 01, 2025
2025 (Q1)
-0.73 / -2.76
14.91-118.51% (-17.67)
May 14, 2025
2024 (Q4)
16.98 / 6.12
-123.512104.95% (+129.63)
Feb 03, 2025
2024 (Q3)
13.90 / 21.46
-20.44204.99% (+41.90)
Oct 30, 2024
2024 (Q2)
-26.98 / -18.90
-26.4228.46% (+7.52)
Aug 02, 2024
2024 (Q1)
-7.34 / 14.91
-20.27173.56% (+35.18)
May 15, 2024
2023 (Q4)
-136.13 / -123.51
-32.608-278.78% (-90.90)
Feb 02, 2024
2023 (Q3)
-19.49 / -20.44
-12.69-61.07% (-7.75)
Nov 01, 2023
2023 (Q2)
0.31 / -26.42
6.77-490.25% (-33.19)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

JP:4005 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
¥453.60¥429.40-5.34%
Aug 01, 2025
¥374.82¥362.29-3.34%
May 14, 2025
¥359.82¥356.76-0.85%
Feb 03, 2025
¥326.62¥317.39-2.83%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sumitomo Chemical Co Ltd (JP:4005) report earnings?
Sumitomo Chemical Co Ltd (JP:4005) is schdueled to report earning on Jan 30, 2026, TBA (Confirmed).
    What is Sumitomo Chemical Co Ltd (JP:4005) earnings time?
    Sumitomo Chemical Co Ltd (JP:4005) earnings time is at Jan 30, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Sumitomo Chemical Co Ltd stock?
          The P/E ratio of Sumitomo Chemical Co is N/A.
            What is JP:4005 EPS forecast?
            JP:4005 EPS forecast for the fiscal quarter 2025 (Q3) is -1.74.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis